Wogonoside improves high-fat diet-induced hyperlipidemia and aortic injury in ApoE -/- mice by upregulating SIRT1 expression
Main Article Content
Keywords
hyperlipidemia, inflammation, oxidative stress, SIRT1, Wogonoside (Wog)
Abstract
This study aimed to evaluate the effect of Wogonoside (Wog), a flavonoid monomer, on hyperlipidemia and explore its possible mechanisms. APOE -/- mice were used to establish the animal model of hyperlipidemia by feeding the high-fat diet (HFD). The serum level of triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), and inflammatory cytokines were measured by enzyme-linked immunosorbent assay (ELISA), oil red O staining, and real-time PCR assay. The oxidative stress was measured by ELISA assay. Immunoblot assay and ELISA assay were used to detect the mechanism of Wogonoside on hyperlipidemia. We found that Wogonoside ameliorated lipid metabolism disorders in ApoE -/- mice induced by HFD (P<0.01). Wogonoside also ameliorated HFD-induced inflammation in ApoE -/- mice (P<0.01). Wogonoside ameliorated oxidative stress in HFD-induced ApoE -/- mice (P<0.01). Further study showed that Wogonoside improved HFD-induced hyperlipidemia and inflammation by upregulating SIRT1 expression (P<0.01). These results suggested that Wogonoside has the potential to be used as a promising approach for the intervention of hyperlipidemia.
References
Cheng Y, Li S, Liu Y, Li J, Chen Y and Zhao H. Treatment of brain edema by Wogonoside is associated with inhibition of neuronal apoptosis and SIRT1 activation in rats. Med Sci Monit. 2020;26:e921250. 10.12659/MSM.921250
Dikme O, Dikme O. Serum cortisol level as a useful predictor of surgical disease in patients with acute abdominal pain. Signa Vitae. 2019;15(1): 27−31. 10.22514/SV151.042019.3
Elsayed MMA, Aboelez MO, Mohamed MS, Mahmoud RA, El-Shenawy AA, Mahmoud EA, et al. Tailoring of rosuvastatin calcium and atenolol bilayer tablets for the management of hyperlipidemia associated with hypertension: A preclinical study. Pharmaceutics. 2022;14(8). 10.3390/pharmaceutics14081629
Kumar S, Chen M, Li Y, Wong FH, Thiam CW, Hossain MZ, Poh KK et al. Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice. Sci Rep. 2016;6:31130. 10.1038/srep31130
Li H, Hui H, Xu J, Yang H, Zhang X, Liu X, et al. Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells. Arch Toxicol. 2016;90(6):1507−22. 10.1007/s00204-015-1552-3
Li H, Xian P, Shi YX, Xie ZY, Liu S and Chen H. Wogonoside induces depalmitoylation and translocation of PLSCR1 and N-RAS in primary acute myeloid leukaemia cells. J Cell Mol Med. 2018;22(4):2117−30. 10.1111/jcmm.13481
Li H, Yu X, Liu X, Hu P, Shen L, Zhou Y, Zhu Y, et al. Discussion on infection prevention and control when media reporters enter into isolation wards during COVID-19 epidemic. Signa Vitae. 2021;17(1): 6−10. 10.22514/sv.2021.001
Liu G, Wei C, Yuan S, Zhang Z, Li J, Zhang L, Wang G, et al. Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1/P53/SLC7A11 pathway. Phytother Res. 2022; 36(11):4230−43. 10.1002/ptr.7558
Su X, Chen X, Wang B. Relationship between the development of hyperlipidemia in hypothyroidism patients. Mol Biol Rep. 2022; 49(11):11025−35. 10.1007/s11033-022-07423-z
Sun Y, Zhao Y, Yao J, Zhao L, Wu Z, Wang Y, et al. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-kappaB and NLRP3 inflammasome activation. Biochem Pharmacol. 2015;94(2):142−54. 10.1016/j.bcp.2015.02.002
Wang Q, Shi R, Dai Y, Li Y, Wang T, Ma Y, et al. Mechanism in the existent difference in form of wogonin/Wogonoside between plasma and intestine/liver in rats. RSC Adv. 2018;8(7): 3364−73. 10.1039/C7RA08270C
Xing S, Wang M, Peng Y and Li X. Effects of intestinal microecology on metabolism and pharmacokinetics of oral Wogonoside and Baicalin. Nat Prod Commun. 2017;12(4): 509−14. PMid: 30520584.
Xu X, Xia J, Zhao S, Wang Q, Ge G, Xu F, et al. Qing-Fei-Pai-Du decoction and Wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2. FASEB J. 2021;35(9): e21870. 10.1096/fj.202100370RR
Yan Y, Yao L, Sun H, Pang S, Kong X, Zhao S, et al. Effects of Wogonoside on invasion and migration of lung cancer A549 cells and angiogenesis in xenograft tumors of nude mice. J Thorac Dis. 2020;12(4):1552−60. 10.21037/jtd-20-1555
Yang YN, Wang QC, Xu W, Yu J, Zhang H and Wu C. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Biomed Pharmacother. 2022;155: 113749. 10.1016/j.biopha.2022.113749
Yilmaz-Yalcin Y, Bascil-Tutuncu N, Baysan-Cebi HP, Verdi H, Erol S, Kaymaz FF, et al. A lipotoxic medium decreases the number of lipid droplets in beta cells: One possible explanation of the beta-cell failure in patients with hyperlipidemia receiving tacrolimus. Exp Clin Transplant. 2022. 10.6002/ect.2022.0269
Zhang B, Xu D. Wogonoside preserves against ischemia/reperfusion-induced myocardial injury by suppression of apoptosis, inflammation, and fibrosis via modulating Nrf2/HO-1 pathway. Immunopharmacol Immunotoxicol. 2022;??:1−9. 10.1080/08923973.2022.2090955
Zhang Y, Hao J, Liu Z, Li Z, Teng L and Wang D. Inonotus hispidus protects against hyperlipidemia by inhibiting oxidative stress and inflammation through Nrf2/NF-kappaB signaling in high fat diet fed mice. Nutrients. 2022;14(17):3477. 10.3390/nu14173477
Zhu SL, Wu QH, Tu J. [Study on regulation of NLRP3/SOCS3-TLR4-NF-kappaB inflammatory pathway by Wogonoside to improve hepatic insulin resistance]. Zhongguo Zhong Yao Za Zhi. 2019;44(20): 4504−10. 10.19540/j.cnki.cjcmm.20190312.002
Zhu Y, Zhu H, Wang Z, Gao F, Wang J and Zhang W. Wogonoside alleviates inflammation induced by traumatic spinal cord injury by suppressing NF-kappaB and NLRP3 inflammasome activation. Exp Ther Med. 2017;14(4):3304−8. 10.3892/etm.2017.4904
Zhou J, Li H, Xun L, Wang L and Zhao Q. Hyperlipidemia attenuates the mobilization of endothelial progenitor cells induced by acute myocardial ischemia via VEGF/eNOS/NO/MMP-9 pathway. Aging (Albany NY). 2022;14(19): 7877−89. 10.18632/aging.204314
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
